Search results
Blueprint Medicines (NASDAQ:BPMC) pulls back 3.5% this week, but still delivers shareholders notable...
Simply Wall St. via Yahoo Finance· 4 hours agoIf you want to compound wealth in the stock market, you can do so by buying an index fund. But...
Insider Buying: Editas Medicine, Inc. (NASDAQ:EDIT) Director Buys $253,800.00 in Stock
ETF DAILY NEWS· 5 days agoEditas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) Director Jessica Hopfield bought 45,000 shares of the firm’s stock in a transaction on Monday, May ...
Revolution Medicines Inc [RVMD] Anders Jack sells 10,000 Shares for $0.4 million – Knox Daily
Knox Daily· 13 hours agoIt rated RVMD as “a Buy” which previously was an “a Neutral”. Price Performance Review of RVMD On Monday, Revolution Medicines Inc [NASDAQ:RVMD] saw its ...
HeartBeam (NASDAQ: BEAT) Announces Positive Study Data for Its AI Program
Digital Journal· 5 hours agoPRESS RELEASE Published May 21, 2024 InvestorBrandNetwork HeartBeam (NASDAQ: BEAT) , a medical technology company focused on transforming cardiac care through the power of ...
Blueprint Medicines Co. (NASDAQ:BPMC) Forecasted to Post Q2 2024 Earnings of ($1.40) Per Share
ETF DAILY NEWS· 6 days agoBlueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Analysts at Zacks Research issued their Q2 2024 earnings per share estimates for shares of Blueprint ...
HC Wainwright Analysts Raise Earnings Estimates for Praxis Precision Medicines, Inc. (NASDAQ:PRAX)
ETF DAILY NEWS· 6 days agoPraxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) – Equities researchers at HC Wainwright raised their Q2 2024 EPS estimates for shares of Praxis ...
Is Madrigal Pharmaceuticals Stock a Buy?
The Motley Fool via AOL· 6 hours agoMadrigal Pharmaceuticals will focus Rezdiffra's launch on roughly 315,000 NASH patients with moderate to advanced fibrosis who are being seen by...
Praxis Precision Medicines, Inc. to Post Q1 2025 Earnings of ($1.89) Per Share, HC Wainwright...
ETF DAILY NEWS· 5 days agoPraxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) – Investment analysts at HC Wainwright issued their Q1 2025 EPS estimates for Praxis Precision ...
Avadel Pharmaceuticals appoints new board member By Investing.com
Investing.com· 4 hours agoAvadel Pharmaceuticals plc (NASDAQ:AVDL), a company specializing in developing innovative...
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring
Motley Fool via Yahoo Finance· 8 hours agoThat would be a major catalyst for the stock. External developments could have big implications The...
